Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8
Closed -$362 1131
2024
Q2
$362 Hold
8
﹤0.01% 975
2024
Q1
$500 Sell
8
-166
-95% -$9.93K ﹤0.01% 937
2023
Q4
$9.75K Hold
174
﹤0.01% 820
2023
Q3
$9.18K Hold
174
﹤0.01% 832
2023
Q2
$11.2K Sell
174
-85
-33% -$4.84K ﹤0.01% 793
2023
Q1
$13.9K Sell
259
-14,370
-98% -$833K ﹤0.01% 766
2022
Q4
$783K Sell
14,629
-3,268
-18% -$169K 0.02% 206
2022
Q3
$825K Sell
17,897
-15,358
-46% -$833K 0.02% 194
2022
Q2
$1.83M Sell
33,255
-30,484
-48% -$1.97M 0.05% 149
2022
Q1
$4.37M Buy
63,739
+17,038
+36% +$1.21M 0.1% 112
2021
Q4
$3.69M Buy
46,701
+1,148
+3% +$96K 0.08% 125
2021
Q3
$3.6M Sell
45,553
-102
-0.2% -$8.2K 0.09% 126
2021
Q2
$3.6M Sell
45,655
-935
-2% -$71.6K 0.09% 126
2021
Q1
$3.51M Hold
46,590
0.09% 125
2020
Q4
$3.07M Sell
46,590
-7,424
-14% -$434K 0.08% 129
2020
Q3
$2.92M Sell
54,014
-393
-0.7% -$21.6K 0.09% 121
2020
Q2
$2.61M Sell
54,407
-3,303
-6% -$146K 0.09% 124
2020
Q1
$1.97M Sell
57,710
-10,044
-15% -$552K 0.08% 127
2019
Q4
$4.24M Buy
67,754
+4,486
+7% +$254K 0.14% 100
2019
Q3
$3.16M Buy
63,268
+1,592
+3% +$75.2K 0.11% 111
2019
Q2
$2.98M Buy
61,676
+52,380
+563% +$2.52M 0.11% 118
2019
Q1
$475K Buy
+9,296
New +$408K 0.02% 206

Other funds holding ENOV

HM Payson & Co's ENOV Position: Q3 2024 in Review

HM Payson & Co sold out of Enovis (ENOV) in Q3 2024, closing a stake of 8 shares — an estimated $362 sold.

HM Payson & Co first reported a position in ENOV in Q1 2019 and held it in 22 quarters. The position peaked at $4.37M in Q1 2022. 283 funds tracked by Wall St. Rank hold ENOV as of Q3 2024.

  • HM Payson & Co reported no remaining Enovis position as of Q3 2024 after selling out during the quarter.
  • HM Payson & Co sold 8 Enovis shares in Q3 2024, an estimated $362.
  • HM Payson & Co first reported a position in Enovis in Q1 2019 and held it in 22 quarters.
  • HM Payson & Co's Enovis position peaked at $4.37M in Q1 2022.
  • 283 funds tracked by Wall St. Rank held Enovis as of Q3 2024.

Based on HM Payson & Co's 13F filing for Q3 2024, filed 28 Oct 2024.